Universität Wien FIND

Due to the COVID-19 pandemic, changes to courses and exams may be necessary at short notice (e.g. cancellation of on-site teaching and conversion to online exams). Register for courses/exams via u:space, find out about the current status on u:find and on the moodle learning platform.

Further information about on-site teaching and access tests can be found at https://studieren.univie.ac.at/en/info.

Warning! The directory is not yet complete and will be amended until the beginning of the term.

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2021W)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work
MIXED

Präsenz oder Hybrid oder Online, je nach Situation.

Details

Language: English

Lecturers

Classes (iCal) - next class is marked with N

Monday 04.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Tuesday 05.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Wednesday 06.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Thursday 07.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Friday 08.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Monday 11.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Tuesday 12.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Wednesday 13.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Thursday 14.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Friday 15.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Monday 18.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Aims, contents and method of the course

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Assessment and permitted materials

There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the material collected during the class and the studies for the class.

Minimum requirements and assessment criteria

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.

Examination topics

All topics covered during the course.

Reading list

Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Association in the course directory

Last modified: We 22.09.2021 13:30